C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction
- PMID: 15472120
- DOI: 10.1161/01.RES.0000147309.54227.42
C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction
Abstract
C-reactive protein (CRP), a characteristic inflammatory marker, is a powerful predictor of cardiovascular events. Recent data suggest that CRP may also promote atherogenesis through inducing endothelial dysfunction. Lectin-like oxidized low-density lipoprotein (oxLDL) receptor-1 (LOX-1) is a newly identified endothelial receptor for oxLDL that plays a pivotal role in oxLDL-induced endothelial dysfunction. Whether CRP may regulate endothelial LOX-1 and induce endothelial dysfunction through this receptor is unknown. In the present study, we studied the in vitro effect of CRP on LOX-1 expression in human aortic endothelial cells (HAECs) and the role of LOX-1 in CRP-induced human monocyte adhesion to endothelium and oxLDL uptake by endothelial cells. Incubation of HAECs with CRP enhanced, in a dose- and time-dependent manner, LOX-1 mRNA and protein levels. Induction of LOX-1 protein was already present at 5 microg/mL CRP and reached a maximum at 25 microg/mL. This effect was reduced by antibodies against CD32/CD64, endothelin-1 (ET-1) and interleukin-6 (IL-6). The extent of stimulation of LOX-1 achieved by CRP was comparable to that elicited by high glucose and IL-6 and remained unchanged in presence of these factors. Finally, CRP increased, through LOX-1, both human monocyte adhesion to endothelial cells and oxLDL uptake by these cells. We conclude that CRP enhances endothelial LOX-1 expression and propose a new mechanism by which CRP may promote endothelial dysfunction, that of inducing LOX-1.
Similar articles
-
Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells.J Mol Cell Cardiol. 1999 Dec;31(12):2101-14. doi: 10.1006/jmcc.1999.1041. J Mol Cell Cardiol. 1999. PMID: 10640439
-
Augmented endothelial uptake of oxidized low-density lipoprotein in response to endothelin-1.Clin Sci (Lond). 2002 Aug;103 Suppl 48:9S-12S. doi: 10.1042/CS103S009S. Clin Sci (Lond). 2002. PMID: 12193044
-
Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha.Circ Res. 2007 Feb 16;100(3):381-90. doi: 10.1161/01.RES.0000258023.76515.a3. Epub 2007 Jan 18. Circ Res. 2007. PMID: 17234968
-
The expression and down stream effect of lectin like-oxidized low density lipoprotein 1 (LOX-1) in hyperglycemic state.Acta Med Indones. 2007 Jan-Mar;39(1):36-43. Acta Med Indones. 2007. PMID: 17939209 Review.
-
The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.Can J Cardiol. 2004 Aug;20 Suppl B:32B-36B. Can J Cardiol. 2004. PMID: 15309203 Review.
Cited by
-
C-Reactive Protein in Atherosclerosis-More than a Biomarker, but not Just a Culprit.Rev Cardiovasc Med. 2023 Oct 19;24(10):297. doi: 10.31083/j.rcm2410297. eCollection 2023 Oct. Rev Cardiovasc Med. 2023. PMID: 39077585 Free PMC article. Review.
-
LOX-1 in Cardiovascular Disease: A Comprehensive Molecular and Clinical Review.Int J Mol Sci. 2024 May 12;25(10):5276. doi: 10.3390/ijms25105276. Int J Mol Sci. 2024. PMID: 38791315 Free PMC article. Review.
-
Relationship of Soluble Lectin-Like Low-Density Lipoprotein Receptor-1 (sLOX-1) With Inflammation and Coronary Plaque Progression in Psoriasis.J Am Heart Assoc. 2023 Nov 20;12(22):e031227. doi: 10.1161/JAHA.123.031227. Online ahead of print. J Am Heart Assoc. 2023. PMID: 37982276 Free PMC article.
-
Research Progress of Flavonoids Regulating Endothelial Function.Pharmaceuticals (Basel). 2023 Aug 23;16(9):1201. doi: 10.3390/ph16091201. Pharmaceuticals (Basel). 2023. PMID: 37765009 Free PMC article. Review.
-
Association of circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 with inflammatory markers and urinary albumin excretion in patients with type 2 diabetes.SAGE Open Med. 2021 Dec 17;9:20503121211064468. doi: 10.1177/20503121211064468. eCollection 2021. SAGE Open Med. 2021. PMID: 34992779 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous